Dr. Lum is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4100 John R
Karmanos Cancer Center
Detroit, MI 48201Phone(800) 527-6266
Fax(313) 576-8767- Is this information wrong?
Education & Training
University of ColoradoResidency, Pediatrics, 1975 - 1976
UCSFResidency, Pediatrics, 1973 - 1975
University of California San Francisco School of MedicineClass of 1973
Certifications & Licensure
VA State Medical License 2016 - 2022
MI State Medical License 1989 - 2017
CA State Medical License 1974 - 2015
WA State Medical License Active through 2013- American Board of Pediatrics Pediatrics
Clinical Trials
- Phase I/II Study of Dasatinib in Recipients of Allogeneic Stem Cell Transplantation for Hematologic Malignancies. Start of enrollment: 2012 May 01Uberti, J.P.,Schiffer, C.A.,Ratanatharathorn, V.,Lum, L.G.,Ayash, L.J.
- Phase I/II Study of Dasatinib in Recipients of Autologous Stem Cell Transplantation for Hematologic Malignancies. Start of enrollment: 2012 May 01Ayash, L.J.,Uberti, J.P.,Schiffer, C.A.,Ratanatharathorn, V.,Lum, L.G.
- Treatment of Advanced Colorectal or Pancreatic Cancer With Anti-CD3 x Anti-EGFR-Armed Activated T-Cells (Phase Ib) Start of enrollment: 2011 Aug 01Choi, M.
- Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Women With HER2/Neu-Negative Metastatic Breast Cancer Start of enrollment: 2011 Feb 01Lum, L.
- Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer Undergoing Surgery Start of enrollment: 2010 Jul 01Lum, L.
- Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Start of enrollment: 2007 Oct 01Lum, L.G.
- Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer Start of enrollment: 2007 Aug 01Lum, L.G.
- Join now to see all
Publications & Presentations
PubMed
- Granzyme B Is a Biomarker For Suspicion of Malignant Seromas Around Breast Implants.Marshall E. Kadin, John Morgan, Haiying Xu, Caroline A Glicksman, David A. Sieber, William P. Adams, Pat McGuire, Mark W. Clemens, Archana Thakur, Lawrence G. Lum> ;Aesthetic Surgery Journal. 2020 Nov 9
- Anti-tumor and immune modulating activity of T cell induced tumor-targeting effectors (TITE)Archana Thakur, Sri Vidya Kondadasula, Kyungmin Ji, Dana Schalk, Edwin T. Bliemeister, Johnson Ung, Amro Aboukameel, Eli V. Casarez, Bonnie F. Sloane, Lawrence G. Lum> ;Cancer Immunology, Immunotherapy. 2020 Aug 31
- Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients.Lawrence G. Lum, Archana Thakur, Minsig Choi, Abhinav Deol, Vidya Kondadasula, Dana Schalk, Kristie Fields, Melissa Dufrense, Philip A. Philip, Gregory Dyson, Hussein ...> ;OncoImmunology. 2020 Jun 10
- Join now to see all
Lectures
- Phase II clinical trial using anti-CD3 x anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) for HER2-negative (0-2+) metastatic breast cancer.2019 ASCO Annual Meeting - 6/1/2019
- Clinical and immune responses using anti-CD3 x anti-EGFR bispecific antibody armed T cells (BATs) for locally advanced or metastatic pancreatic cancer.2019 ASCO Annual Meeting - 6/1/2019
- Targeting advanced pancreatic cancer with activated t cells armed with anti-CD3 x anti-EGFR bispecific antibody.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
Pax6 Organizes the Anterior Eye Segment by Guiding Two Distinct Neural Crest WavesJune 18, 2020 09:40
Q&A: Cancer Death Rates Are Falling Nationally. Here’s What’s Happening at UVAJanuary 16, 2020 08:08
Researchers Find Cancer Drug Can Regenerate Heart TissuesFebruary 07, 2017 11:05- Join now to see all
Grant Support
- Enhancing Neoadjuvant Chemotherpay Responses With Targeted T CellsNational Cancer Institute2010–2012
- Breast Cancer Treatment With Antibody Targeted T CellsNational Cancer Institute2006–2011
- Chemical Disruption Of The HH And WNT Pathways In Vertebrate DevelopmentEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2010
- Hedgehog Signal Transduction Across The Cell MembraneNational Institute Of General Medical Sciences2006–2010
- Breast Cancer Treatment With Antibody Targeted T CellsNational Cancer Institute2002–2006
- Cornell-Rockefeller-Sloan-Kettering MST ProgramNational Institute Of General Medical Sciences1994–1996
- Rockefeller-Cornell-Sloan Kettering MST ProgramNational Institute Of General Medical Sciences1993
- B Cell Function And Antigen-Specific Immune ResponseNational Cancer Institute1987
- Reconstitution Of Immunologic Reactivity In Marrow Graft RecipientsNational Cancer Institute1985–1986
Professional Memberships
- Member
Hospital Affiliations
DMC - Detroit Receiving HospitalDetroit, Michigan
DMC Harper University HospitalDetroit, Michigan- Emily Couric Clinical Cancer CenterCharlottesville, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
